Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
366.20
+27.61 (8.15%)
At close: Feb 4, 2026, 4:00 PM EST
364.60
-1.60 (-0.44%)
After-hours: Feb 4, 2026, 7:58 PM EST
Amgen Employees
Amgen had 28,000 employees as of December 31, 2024. The number of employees increased by 1,300 or 4.87% compared to the previous year.
Employees
28,000
Change (1Y)
1,300
Growth (1Y)
4.87%
Revenue / Employee
$1,312,536
Profits / Employee
$275,393
Market Cap
197.19B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 28,000 | 1,300 | 4.87% |
| Dec 31, 2023 | 26,700 | 1,500 | 5.95% |
| Dec 31, 2022 | 25,200 | 1,000 | 4.13% |
| Dec 31, 2021 | 24,200 | -100 | -0.41% |
| Dec 31, 2020 | 24,300 | 900 | 3.85% |
| Dec 31, 2019 | 23,400 | 1,900 | 8.84% |
| Dec 31, 2018 | 21,500 | 700 | 3.37% |
| Dec 31, 2017 | 20,800 | 1,600 | 8.33% |
| Dec 31, 2016 | 19,200 | 1,300 | 7.26% |
| Dec 31, 2015 | 17,900 | 0 | - |
| Dec 31, 2014 | 17,900 | -2,100 | -10.50% |
| Dec 31, 2013 | 20,000 | 2,000 | 11.11% |
| Dec 31, 2012 | 18,000 | 200 | 1.12% |
| Dec 31, 2011 | 17,800 | 400 | 2.30% |
| Dec 31, 2010 | 17,400 | 200 | 1.16% |
| Dec 31, 2009 | 17,200 | 300 | 1.78% |
| Dec 31, 2008 | 16,900 | -600 | -3.43% |
| Dec 31, 2007 | 17,500 | -2,600 | -12.94% |
| Dec 31, 2006 | 20,100 | 3,600 | 21.82% |
| Dec 31, 2005 | 16,500 | 2,100 | 14.58% |
| Dec 31, 2004 | 14,400 | 1,500 | 11.63% |
| Dec 31, 2003 | 12,900 | 2,800 | 27.72% |
| Dec 31, 2002 | 10,100 | 2,400 | 31.17% |
| Dec 31, 2001 | 7,700 | 400 | 5.48% |
| Dec 31, 2000 | 7,300 | 900 | 14.06% |
| Dec 31, 1999 | 6,400 | 900 | 16.36% |
| Dec 31, 1998 | 5,500 | 192 | 3.62% |
| Dec 31, 1997 | 5,308 | 662 | 14.25% |
| Dec 31, 1996 | 4,646 | 600 | 14.83% |
| Dec 31, 1995 | 4,046 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,100 |
| AstraZeneca | 92,900 |
| Sanofi | 82,878 |
| Pfizer | 81,000 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,267 |
| Merck & Co. | 75,000 |
| GSK plc | 68,629 |
AMGN News
- 14 hours ago - Why Amgen Stock Is Paying Off Big For Long-Term Investors - Forbes
- 17 hours ago - Amgen: Strong Mitigation Of LOE Impact, Regulatory Tensions On Tavneos Emerge - Seeking Alpha
- 1 day ago - Amgen Inc. (AMGN) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Amgen Logs Higher Fourth-Quarter Revenue on Double-Digit Volume Boost - WSJ
- 1 day ago - Amgen quarterly results beat Street estimates on higher sales, lower tax rate - Reuters
- 1 day ago - AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS - PRNewsWire
- 1 day ago - Obesity stocks slump on Novo's underwhelming 2026 sales forecast - Reuters
- 5 days ago - Kyowa Kirin Regains Global Rights To Atopic Dermatitis Drug After Amgen Collaboration Ends - Benzinga